Cambridge Healthtech Institute’s 4th Annual

Generative AI for Drug Discovery

Designing Novel Modalities, Optimizing Drug Candidates, Closing the DMTA Loop

April 19, 2027


Generative AI (GenAI) models and algorithms show promise in designing and optimizing lead candidates with desirable drug-like properties and for exploring complex biology and expansive chemical space. However, do we fully understand their scope, impact, and nuances for early drug discovery applications? Cambridge Healthtech Institute’s symposium on Generative AI for Drug Discovery will bring together key stakeholders from pharma/biotech companies, technology providers, and academia to discuss what is currently being done and what is possible in the near future. These discussions on applications of GenAI are a good primer for the AI/ML for Early Drug Discovery conferences that follow.

Coverage will likely include:

  • De novo small molecule design: Progress on AI-generated drug candidates
  • Performance and scalability of generative AI models for designing large molecules
  • Multi-Parameter lead optimization using genAI predictions
  • Closed loop generative discovery for Design-Make-Test-Analyze (DMTA) integration
  • Gen AI-guided linkers, degrader architectures, and molecular glue chemotypes
  • Foundation and generative models for predicting drug-like properties and drug responses
  • Agentic AI and autonomous medicinal chemistry
  • Overview of existing limitations, reality checks, and strategies for bridging gaps

The deadline for priority consideration is October 5, 2026.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation:


For more details on the conference, please contact:
Tanuja Koppal, PhD
Senior Conference Director
Cambridge Healthtech Institute
Email: tkoppal@healthtech.com

For sponsorship information, please contact:
Kristin Skahan
Senior Business Development Manager
Cambridge Healthtech Institute
Phone: (+1) 781-972-5431
Email: kskahan@healthtech.com


Register Early for Maximum Savings

APRIL 19

Covalent & Induced Proximity-Based Therapies

RNA-Modulating Small Molecule Drugs

Generative AI for Drug Discovery

training seminars

View In-Person Short Courses

APRIL 20 - 21

Degraders & Molecular Glues - Part 1

Small Molecule Discovery Technologies

AI/ML for Early Drug Discovery - Part 1

Linker & Conjugation Chemistries

Peptides

APRIL 21 - 22

Degraders & Molecular Glues - Part 2

Protein-Protein Interactions / Difficult Targets

AI/ML for Early Drug Discovery - Part 2

DNA-Encoded Libraries

GLP1 & Oral Peptides


Drug Discovery Chemsitry Europe

View All Sponsors

View All Media Partners